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Summary  This  study  investigated  the  distribution  of  serotype  and  antimicrobial
susceptibility  of  Streptococcus  pneumoniae  carried  by  adults  infected  with  human
immunodeﬁciency  virus  (HIV)  in  Jakarta,  Indonesia.  Specimens  of  nasopharyngeal
swab  were  collected  from  200  HIV  infected  adults  aged  21  to  63  years.  IdentiﬁcationHIV;
Adults;
Jakarta
of  S.  pneumoniae  was  done  by  optochin  susceptibility  test  and  PCR  for  the  presence
of  psaA  and  lytA  genes.  Serotyping  was  performed  with  sequential  multiplex  PCR
and  antibiotic  susceptibility  with  the  disk  diffusion  method.  S.  pneumoniae  strains
were  carried  by  10%  adults  with  serotype  6A/B  20%  was  common  serotype  among
cultured  strains  in  20  adults.  Most  of  isolates  were  susceptible  to  chlorampheni-
col  (80%)  followed  by  clindamycin  (75%),  erythromycin  (75%),  penicillin  (55%),  and
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tetracycline  (50%).  This  study  found  resistance  to  sulphamethoxazole/trimethoprim
was  most  common  with  only  15%  of  strains  being  susceptible.  High  non-susceptibility
to  sulphamethoxazole/trimethoprim  was  observed  in  S.  pneumoniae  strains  carried
by  HIV  infected  adults  in  Jakarta,  Indonesia.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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merase chain  reaction  (PCR)  as  described  previously
[14,15].  A  sequential  multiplex  PCR  (SM-PCR)  was
performed  for  serotyping  with  an  internal  positive©  2016  King  Saud  Bin  Ab
Limited.  All  rights  reserv
Introduction
Streptococcus  pneumoniae  infection  is a major
worldwide cause  of  morbidity  and  mortality  espe-
cially in  low  income  countries  where  pneumococcal
conjugate vaccines  (PCVs)  are  still  underused  [1]. S.
pneumoniae  carriage  is  considered  to  be  an  impor-
tant source  of  horizontal  spread  of  this  pathogen
within the  community  [2,3]. The  epidemiology
data of  carriage  for  S.  pneumoniae  in  developing
countries is  crucial  for  implementing  appropriate
vaccination strategies  and  evaluating  their  impact
[1].
Human  immunodeﬁciency  virus  (HIV)  infection
and AIDS  increase  the  risk  of  invasive  pneumococ-
cal disease  (IPD)  [4]. Underlying  HIV  infection  is  an
important  risk  factor  for  pneumonia  morbidity  and
mortality  in  children  [5]. S.  pneumoniae  is  the  lead-
ing bacterial  opportunistic  infection  in  HIV  positive
individuals  [6].  Although,  anti-retroviral  treatment
(ART)  reduces  their  risk  of  IPD,  however,  it  remains
20- to  40-fold  greater  than  that  of  the  general  pop-
ulation [6].
The  carriage  prevalence  of  S.  pneumoniae  in
HIV-infected children  was  76%  of  90  participants
in Kiliﬁ,  Kenya  [7]. Meanwhile,  S.  pneumoniae  car-
riage among  adults  infected  with  HIV  age  18  year
or older  were  17%  and  18%  in  Brazil  and  Uganda
respectively  [8,9]. Onwubiku  et  al.  reported  this
carriage of  S.  pneumoniae  was  3.4%  in  HIV-infected
patients after  the  introduction  of  PCV  vaccination
[10].  However,  vaccination  of  HIV-infected  mothers
with pneumococcal  polysaccharide  vaccine  (PPV)
did not  protect  infants  younger  than  6  months  of
age from  nasopharyngeal  pneumococcal  carriage
[11].  Recently  we  reported  that  S.  pneumoniae  car-
riage in  HIV-infected  children  (aged  4—144  months)
was  46%  in  Jakarta,  Indonesia  [12].  In  this  present
study,  we  investigated  S.  pneumoniae  carriage  in
HIV adults  (aged  21—63  years)  in  Jakarta,  Indonesia.
This study  will  provide  the  epidemiology  data  of  S.
pneumoniae  carried  by  adults  with  HIV  infection  in
Indonesia.
c
c
pethods
pecimen collection
 cross-sectional  survey  on  serotype  and  antibi-
tic susceptibility  of  S.  pneumoniae  was  performed
n HIV-infected  adults  at  the  Unit  Pelayanan
erpadu HIV  (HIV  Integrated  Services),  Cipto
angunkusumo  Hospital,  Jakarta,  Indonesia  from
ugust to  October  2012.  This  study  has  been
eviewed and  approved  by  the  ethical  commit-
ee of  the  Faculty  of  Medicine,  University  of
ndonesia, Jakarta,  Indonesia.  The  participants
igned informed  consent  and  provided  demographic
nformation, such  as  age,  sex,  family  member,  and
moking.  Detailed  medical  information  on  CD4  lym-
hocyte count  within  the  past  3 months,  use  of
ighly active  antiretroviral  therapy  (HAART),  and
se of  antibiotics  was  recorded  during  the  study.
asopharyngeal swab  specimens  we  collected  using
 ﬂexible  nasopharyngeal  ﬂoxed  swab  (Copan,  Italy
o 503SC01)  in  skim  milk  tryptone  glucose  glycerol
STGG) transport  medium  as  described  previously
12]. The  specimen  of  STGG  sample  was  plated  onto
 5%  sheep  blood  agar  supplemented  with  5  mg/L
entamicin  (SB-Gent),  and  incubated  at  35 ◦C  for
4 h  with  5%  CO2. When  alpha-hemolytic  colonies
rowth on  the  SB-Gent  plate,  a single  colony  was
e-cultured  and  tested  by  Gram-staining  and  tested
or susceptibility  to  optochin.
olecular identiﬁcation of Streptococcus
neumoniae  strain
acterial  DNA  was  extracted  as  described  previ-
usly [13].  S.  pneumoniae  strain  was  identiﬁed
y the  presence  of psaA  and  lytA  genes  by poly-ontrol  targeting  160  bp  fragment  of  capsule  trans-
riptional  regulator  gene  wzg  (cpsA)  universally
resent in  cps  operons  of  almost  all  serotypes  [13].
S.  pneumoniae  in  adults  with  HIV  635
Table  1  Patient  characteristics  related  to  Strepto-
coccus  pneumoniae  carriage.
Characteristics  N  N  (%)  of  adult
carrying  S.
pneumoniae
HIV-infected  adults  200  20  (10)
Age  (year)
21—30  59  5  (8)
31—40  105  14  (13)
41—50  27  2  (7)
>50  9  0  (0)
Sex
Male  126  12  (10)
Female  74  9  (12)
Smoking
Yes  88  11  (13)
No  of  family  member
1—3  128  17  (13)
4—6  54  4  (7)
≥7  17  0  (0)
Current  antibiotics  use
Yes 81  9  (11)
Current  HAART  use
Yes  175  20  (11)
CD4  lymphocyte  counta
<200  cells/uL  46  3  (7)
200—500  cells/uL  68  6  (9)
>500  cells/uL  22  2  (9)
HAART = highly active antiretroviral therapy.
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Table  2  Serotype  distribution  among  Streptococcus
pneumoniae  strains  isolated  from  HIV-infected  adults
in  Jakarta,  Indonesia.
Serotype  N  (%)
6A/B  4  (20)
11A  2  (10)
15B/C  2  (10)
19F  1  (5)
19A  1  (5)
17F  1  (5)
23F  1  (5)
3  1  (5)
34  1  (5)
Untypeable
cpsA  positive  3  (15)
cpsA  negative  3  (15)
PCV-13  coverage  8  (40)
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va CD4 lymphocyte count measured within 3 months prior
to nasopharyngeal sampling.
ntibotic susceptibility testing
ll  isolates  were  tested  for  antibiotic  suscepti-
ility using  the  disk  diffusion  method  according
o CLSI  standard  with  six  antimicrobial  disks
Oxoid): chloramphenicol,  clindamycin,  erythromy-
in, sulfamethoxazole/trimethoprim,  tetracycline,
xacillin for  susceptibility  to  penicillin  [16].
ata analysis
roportions  of  isolates  were  compared  by  using
wo-tailed Fisher’s  exact  test.  A  p-value  <0.05  was
onsidered  statistically  signiﬁcant.
esultswo  hundred  swab  samples  were  collected  from
IV-infected adults.  The  patient  characteristics  are
escribed in  Table  1.  The  age  of  the  adults  are
l
o
(
cetween  21  and  63  years  and  over  50%  (n  =  105)
ith aged  30—40  years.  The  adults  with  smoking
nd living  with  three  or  less  family  members  were
8 (44%)  and  128  (64%)  respectively.  Most  of  the  HIV-
nfected adults  were  receiving  HAART  (n  =  175;  88%)
nd 81  of  200  adults  (41%)  were  current  antibiotic
se (Table  1).  Out  of  the  136  adults  with  known
D4 counts,  46  of  them  had  CD4  counts  less  than
00 cells/L,  68  of  patients  with  range  CD4  count
00—500 cells/l  and  22  of  patients  with  a CD4
ount >500  cells/L  (Table  1).
This study  found  S.  pneumoniae  strains  carried
y 20  adults  (10%)  were  susceptible  to  optochin
usceptibility test  and  PCR  positive  for  psaA  and
ytA genes.  Fourteen  strains  were  cultured  from
he adults  with  aged  31—40  years  (13%)  (Table  1).
here were  no  difference  with  regard  of  sex,  smok-
ng, numbers  of  family  member,  current  antibiotics
se, CD4  count,  between  those  with  and  without
olonization of  S.  pneumoniae  (p  value  >0.05).  All
neumococcal  isolates  were  obtained  from  patients
eceiving  HAART  (Table  1).
We identiﬁed  four  strains  as  6A/B  (20%)  fol-
owed by  two  strains  (10%)  for  each  serotype
1A and  15B/C;  and  one  strain  for  each  serotype
9F, 17F,  19A,  23F,  3,  and  34  (Table  2).  In  this
tudy, we  identiﬁed  that  six  isolates  were  unty-
eable using  the  SM-PCR  method,  with  three  of
hose six  also  being  PCR-negative  for  the  cpsA
ene. Strains  that  could  be  covered  by  the  PCV
accination are  40%  for  PCV13  vaccine  formu-
ation (Table  3).  This  study  found  the  majority
f isolates  were  susceptible  to  chloramphenicol
80%), followed  by  clindamycin  (75%),  erythromy-
in (75%),  tetracycline  (50%),  penicillin  (55%)  and
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Table  3  Antimicrobial  susceptibility  of  Streptococ-
cus  pneumoniae  strains  carried  by  HIV-infected  adults.
Antimicrobial  agent  Number  (%)  of
susceptible
isolates
Chloramphenicol  16  (80)
Clindamycin  15  (75)
Erythromycin  15  (75)
Penicillina 11  (55)
Tetracycline  10  (50)
Sulphamethoxazole/trimethoprim  3  (15)
Table  4  Pattern  of  antimicrobial  resistant  S.  pneu-
moniae  strains.
Non  susceptible
to  any
antimicrobial
agent:
Isolatea Antimicrobial
patternb
One  (n  =  6)
RID  48 SXT
RID  49  SXT
RID  56  SXT
RID  102  SXT
RID  106  SXT
RID  120  SXT
Two  (n  =  4)
RID 94  TET-CHL
RID  108  SXT-PEN
RID  131  SXT-PEN
RID  179  SXT-PEN
Three  or  more
(n  =  9)
RID  86  SXT-TET-CHL
RID  97  SXT-TET-CHL
RID  42  SXT-TET-PEN
RID  66  SXT-TET-PEN
RID  57 TET-PEN-CLI-
ERY
RID 24 SXT-TET-CLI-
ERY
RID 80  SXT-TET-PEN-
CLI-ERY
RID  204  SXT-TET-PEN-
CLI-ERY
RID  124  SXT-TET-PEN-
CLI-ERY-CHL
a One isolate (RID 26) was susceptible to all of the antimi-
crobial agents tested.
b SXT: Sulphamethoxazole/trimethoprim; TET: Tetracy-
cline; CHL: Chloramphenicol; PEN: Penicillin; CLI: Clin-
damycin; ERY: Erythromycin.
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wa Susceptibility to penicillin was determined with oxacillin
disk [12].
sulphamethoxazole/trimethoprim  (15%)  (Table  3).
We identiﬁed  nine  of  isolates  (45%)  expressed  a
lack of  susceptibility  to  three  or  more  antimicrobial
agents of  different  classes  thus  considered  multi-
drug resistant  (Table  4).
Discussion
We  found  nasopharyngeal  carriage  of  S.  pneumo-
niae was  10%  among  200  of  HIV-infected  adults
aged 21—63  years  in  Jakarta,  Indonesia.  In  this
study, the  S.  pneumoniae  carriage  in  adults  was
lower  than  in  HIV-infected  children  (46%)  [12]
or  in  healthy  children  in  Lombok  Island  (48%)
or Semarang  (43%),  Indonesia  [17,18]. This  result
was in  line  with  previous  study  in  the  Ugandan
adults with  HIV  infection  (18%)  [8]  and  also  adults
aged  45—75  years  in  Semarang,  Indonesia  (11%)
[18]  but  higher  than  older  adults  aged  60—97  in
Jakarta,  Indonesia  (3%)  [19]. Meanwhile,  Onwu-
biko  et  al.  reported  the  carriage  was  3.4%  in
HIV-infected patients  (≥18  years  of  age)  after
the introduction  of  the  PCV  vaccination  vaccine
[10].
In this  study,  most  of  HIV-infected  adults  (88%)
were  receiving  HAART.  The  widespread  introduc-
tion of  HAART  was  reported  declining  the  incidence
of IPD  in  HIV-infected  patients  [20,21].  However,
Siemieniuk et  al.  reported  the  incidence  of  IPD
remains high  in  HIV  patients  with  its  associated  mor-
bidity and  mortality  after  the  widespread  use  of
HAART and  PPV  immunization  in  Southern  Alberta,
Canada  [22].  We  observed  the  number  of  serotype  6
A/B isolates  (20%)  are  in  line  with  previous  studies
in healthy  children  in  Lombok,  Indonesia  (serogroup
6; 25%)  and  in  children  and  adults  in  Semarang,
Indonesia (serotype  6A/B;  19%)  [17,18].  Meanwhile,
in the  HIV-infected  children  in  Jakarta,  serotype
19F isolates  were  the  most  common  in  the  carriage
[12].
A
p
i
sAntibiotic  prophylaxis  of  sulfamethoxa-
ole/trimethoprim  has  long  been  recommended
or immunosuppressed  HIV-infected  adults  and
hildren  born  to  HIV-infected  women  and  there
as some  evidence  that  this  prophylaxis  protects
gainst resistance  to  other  antibiotics  [23,24,25].
his antibiotic  is  an  inexpensive,  broad-spectrum
ntimicrobial  drug  that  is  widely  used  in  devel-
ping countries  [25].  In  this  study,  we  found  high
requency  of  sulphamethoxazole/trimethoprim-
on susceptible  S.  pneumoniae  in  HIV-infected
dults (only  15%  isolates  were  still  susceptible
o this  antimicrobial  drug).  This  result  is  in  line
ith previous  studies  in  HIV-infected  patients  in
frica [8,26,27]. Meanwhile,  forty-one  percent  S.
neumoniae  isolated  from  in  HIV-infected  children
n Jakarta,  Indonesia  were  still  susceptible  to
ulfamethoxazole/trimethoprim  [12].
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onclusion
.  pneumoniae  strains  carried  by  HIV-infected
dults was  lower  than  HIV-infected  children.  High
requency  of  sulphamethoxazole/trimethoprim-
on  susceptible  S.  pneumoniae  was  found  in
IV-infected adults  in  Jakarta,  Indonesia.  Our  ﬁnd-
ngs provide  on  the  epidemiology  data  on  S.
neumoniae carriage  in  high  risk  population  in
ndonesia.
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